Vicore Announces The Nomination Committee For The 2026 Annual General Meeting
STOCKHOLM, SE / ACCESS Newswire / November 3, 2025 / Vicore Pharma Holding (STO:VICO) – Stockholm, November 3, 2025 – Vicore Pharma Holding AB (publ)(STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), has appointed the Nomination Committee for the 2026 Annual General Meeting (AGM). The three […]